粒子工程路线对波萨可纳溶解性能的影响
Tianyi Xiang1, Zijian Wang1, Marina Solomos2
1Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
International journal of pharmaceutics
|December 6, 2024
概括
微缩波萨可纳晶体的不同制造方法显著影响药物溶解. 用表面活性剂进行预处理提高了粉末的分散性,使生物制药性能预测的溶解速率能够有意义地评估.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
背景情况:
- 微缩药物晶体可以显示由于分子异构性而具有可变的制药性质,即使具有相似的颗粒大小.
- 波萨可纳对压力诱导无形化的倾向使传统的溶解测试方法 (如内在溶解) 变得复杂.
研究的目的:
- 为了评估通过和沉制备的微化波萨可纳的溶解性能.
- 评估聚合物涂层和表面活性剂预处理对溶解特性的影响.
主要方法:
- 使用粉末溶解测试,以避免压力诱导的无形化.
- 表面活性剂辅助预处理用于解决微化波萨可纳粉末的湿透性和分散性差.
- 在分析中考虑了在预处理过程中形成的波萨可纳水合物.
主要成果:
- 在磨粉和沉产生的波萨可纳粉之间观察到溶解速率的差异.
- 表面活性剂预处理成功提高了粉末的分散性,允许进行有意义的溶解测量.
- 在预处理过程中发生了可纳酸盐的形成,这也与体内条件有关.
结论:
- 制造途径显著影响了微化波萨可纳的溶解性能.
- 粉末溶解与适当的预处理是一种可行的方法来表征API工程影响.
- 了解溶解变异性对于预测工程制药颗粒的生物制药性能至关重要.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
727
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
727
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
174
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
174
Factors Influencing Drug Absorption: Drug Dissolution
415
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
415
Factors Influencing Drug Absorption: Pharmaceutical Parameters
119
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
119
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.1K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.1K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
284
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
284


